Free Trial

Anterix (NASDAQ:ATEX) Share Price Breaks Above 50-Day Moving Average - What's Next?

Anterix logo with Communication Services background
Image from MarketBeat Media, LLC.

Key Points

  • Anterix shares moved above their 50-day moving average, which stands at $81.22, and recently traded at $82.69 after reaching $88.99.
  • Quarterly results were mixed: the loss per share of $0.25 was narrower than expected, while revenue of $1.96 million fell short of estimates. The company also cited 16 active opportunities and $107.5 million in cash.
  • Analysts’ average rating is Moderate Buy, with a consensus price target of $131.33, though ratings range from Sell to Strong Buy. Recent reports also noted insider stock sales.
  • Interested in Anterix? Here are five stocks we like better.

Shares of Anterix Inc. (NASDAQ:ATEX - Get Free Report) passed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $81.22 and traded as high as $88.99. Anterix shares last traded at $82.69, with a volume of 484,445 shares changing hands.

Trending Headlines about Anterix

Investors following ATEX have been watching these headlines:

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Wall Street Zen lowered shares of Anterix from a "hold" rating to a "sell" rating in a research report on Saturday, August 15th. JPMorgan Chase & Co. decreased their price target on Anterix from $133.00 to $130.00 and set an "overweight" rating on the stock in a report on Thursday, August 13th. DA Davidson set a $161.00 target price on shares of Anterix in a research report on Friday, August 21st. B. Riley Financial upgraded shares of Anterix from a "neutral" rating to a "buy" rating and increased their price target for the company from $86.00 to $103.00 in a research report on Thursday. Finally, Clear Str upgraded Anterix to a "strong-buy" rating in a report on Monday, July 27th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Anterix currently has an average rating of "Moderate Buy" and a consensus target price of $131.33.

Read Our Latest Research Report on ATEX

Anterix Price Performance

The firm has a market cap of $1.63 billion, a price-to-earnings ratio of 212.03 and a beta of 0.87. The business has a 50-day moving average of $81.22 and a 200-day moving average of $67.52.

Anterix (NASDAQ:ATEX - Get Free Report) last posted its quarterly earnings results on Tuesday, November 10th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.05. Anterix had a net margin of 96.23% and a negative return on equity of 11.07%. The firm had revenue of $1.96 million for the quarter, compared to analyst estimates of $2.05 million. As a group, equities analysts anticipate that Anterix Inc. will post -2.00 EPS for the current fiscal year.

Insiders Place Their Bets

In other Anterix news, CFO Elena Marquez sold 4,981 shares of the firm's stock in a transaction on Friday, October 9th. The stock was sold at an average price of $80.43, for a total transaction of $400,621.83. Following the completion of the sale, the chief financial officer owned 12,604 shares of the company's stock, valued at $1,013,739.72. This trade represents a 28.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Leslie Daniels sold 2,500 shares of Anterix stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $83.83, for a total transaction of $209,575.00. Following the sale, the director directly owned 43,477 shares of the company's stock, valued at $3,644,676.91. The trade was a 5.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 78,441 shares of company stock worth $6,794,661 in the last quarter. Company insiders own 40.05% of the company's stock.

Institutional Investors Weigh In On Anterix

A number of hedge funds and other institutional investors have recently modified their holdings of ATEX. State of Wyoming bought a new stake in shares of Anterix in the third quarter valued at approximately $27,000. Sterling Capital Management LLC grew its stake in shares of Anterix by 850.0% during the third quarter. Sterling Capital Management LLC now owns 380 shares of the company's stock worth $30,000 after buying an additional 340 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in Anterix in the 2nd quarter worth about $35,000. Parallel Advisors LLC increased its stake in shares of Anterix by 63.7% in the first quarter. Parallel Advisors LLC now owns 933 shares of the company's stock valued at $36,000 after buying an additional 363 shares during the period. Finally, Fifth Third Bancorp acquired a new position in Anterix in the 1st quarter valued at approximately $64,000. Institutional investors and hedge funds own 87.67% of the company's stock.

Anterix Company Profile

(Get Free Report)

Anterix Inc. provides licensed wireless spectrum for private broadband networks, primarily serving electric, gas and water utilities and other critical-infrastructure organizations. Its business focuses on making 900 MHz spectrum available to customers that want dedicated communications networks for operational needs such as grid monitoring, automation and resilience. The company's spectrum holdings cover areas across the United States. Anterix works with utilities and technology partners to support the development of private LTE networks, offering spectrum access and related planning and ecosystem support rather than operating a public mobile network.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anterix Right Now?

Before you consider Anterix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.

While Anterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines